Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ipca Laboratories has informed BSE that its Board of Directors will meet on Friday, 13 February 2026. The main agenda is to consider and approve the standalone and consolidated unaudited financial results for the third quarter (Q3) and nine months ended 31 December 2025. This is a routine regulatory filing under SEBI's Listing Regulations, giving advance notice ahead of the results announcement. The company also reminded that the insider trading window remains closed from 1 January 2026 until 48 hours after the results are declared, i.e. till 15 February 2026. No financial numbers or business details have been disclosed in this filing — it is purely a scheduling notice.
Shareholders should expect the Q3 FY26 earnings to be released shortly after 13 February 2026. The stock may see some activity around the results date, but no fundamental change is signalled by this notice itself.